Unpacking Your Portfolio’s Exposure to China (WisdomTree)

• As the Chinese market continues growing, investors with broad EM exposure have been left with a 33% position in a market that has an incredible amount of both headwinds and tailwinds, making it complicated to implement their specific asset allocation views.
• WisdomTree is launching XC – the WisdomTree Emerging Markets ex-China Fund – which will track the WisdomTree Emerging Markets ex-China Index, which rebalances on an annual basis and provides investors with exposure to non-state-owned companies (non-SOEs) in emerging market countries excluding China.
• Excluding China from a broad EM universe has considerable consequences in terms of fundamentals, sector and country exposures. READ MORE

Similar Posts:

• Is Your Emerging Market Strategy Overexposed to These 3 Factors? (KraneShares)
• Developments in the Reform of China’s State-Owned Enterprises (Mobius Blog)
• Pick Stocks, Not Countries, in Emerging Markets (FE Trustnet)
• Emerging Market Funds Hammer Developed Market Funds in July (Interactive Investor)
• F/X Exposure Hit APAC Corporates (Asset Benchmark Research)
• Shift Your Emerging Market Consumer Exposure from MNCs to Local Stocks (FE Trustnet)
• Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
• China beyond Evergrande: Contagion or containment? (PineBridge Investments)
• China Bolsters Pension Fund as Fears Grow Over 2035 Doomsday (Nikkei Asian Review)
• Barclays: China Fears Being Overplayed (FT Adviser)
• Lazard Emerging Markets Fund Manager: Full-blown Financial Crisis in China is Unlikely (FE Trustnet)
• China to South America: Consumer Technology Growth in Emerging Markets (KraneShares)
• Chinese Manufacturers Get Around US Tariffs With Some Help From Mexico (Bloomberg)
• World Bank Cuts China Growth Forecast as COVID-19, Real-estate Crunch Take Toll (WSJ via Fox Business)
• PwC China Unicorn Survey 2019: Harnessing Innovation For Hypergrowth (PwC)